icenticaftor (QBW251) - Novartis
Icenticaftor: Regulatory submission for COPD in 2025 (Novartis) - Feb 2, 2022 - Q4 & FY 2021 Results 
Regulatory • Chronic Obstructive Pulmonary Disease
https://www.novartis.com/sites/novartis_com/files/q4-2021-investor-presentation.pdf
 
Feb 2, 2022
 
 
bbb64801-a47b-4ace-9eec-728c716ec569.png

8beed171-ad9c-443d-a0b3-40efe123c4ac.png